ObjectiveGI is delivering provider partners and their patients participating in research a new, all-inclusive platform of clinical research data management.
“Our distributed technology further strengthens ObjectiveGI’s relationships with partner physicians by delivering more information and analytics within the framework of their existing patient care workflows,” says Colleen Hoke, CEO. “This ‘frictionless’ information-sharing approach supports mobile engagement for investigators, improving workflow integration and timely access to clinical research data.”
“This collaboration extends our data-driven solutions platform while maintaining our stringent security and data privacy requirements. The Clinical Research IO product infrastructure adheres to a stringent cloud-readiness process with security reviews, penetration testing and redundancy,” says Gerry Andrady, CTO. The new ObjectiveGI platform incorporates a clinical research–based eSource model that accepts multiple data formats and securely transforms those data sets into more comprehensive reporting and analytics. The result is usable information that can be readily reviewed and utilized within trial management.
ObjectiveGI is engaging next generation research systems to leverage resources and accelerate high-quality data collection, thus allowing for more efficient research execution throughout the patient care continuum.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.